Gianluigi Agolino

Dr. Gianluigi Agolino

orcid

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 January 2025 in Biomolecules
Verified
Journal Article
Open access
PDF file
Gianluigi AgolinoGianluigi Agolino
Gianluigi Agolino
Marianna CristofoliniMarianna Cristofolini
Marianna Cristofolini
Amanda VaccalluzzoAmanda Vaccalluzzo
Amanda Vaccalluzzo
Davide TagliazucchiDavide Tagliazucchi
Davide Tagliazucchi
Alice CattivelliAlice Cattivelli
Alice Cattivelli
Cinzia Lucia  RandazzoCinzia Lucia Randazzo
Cinzia Lucia Randazzo
Bile salt hydrolase (BSH; EC 3.5.1.24) is the microbial enzyme that catalyzes the conversion of primary bile acids (BAs) into secondary ones, promoting microbial adaptation and modulating several host’s biological functions. Probiotics with BSH activity are supposed to survive harsh intestinal conditions and exert a cholesterol-lowering effect. Here, Lacticaseibacillus rhamnosus strains (VB4 and VB1), isolated from the vaginal ecosystem, were submitted to a genomic survey, in vitro BSH activity, and BAs tolerance assay to unravel their probiotic potential as BAs modulators. The draft genomes of Lcb. rhamnosus VB4 and VB1 strains comprised 2769 and 2704 CDSs, respectively. Gene annotation revealed numerous strain-specific genes involved in metabolism and transport, as well as in DNA recombination. Each strain harbors a single bsh gene, encoding a C-N amide hydrolase, which conserved the essential residues required in the BSH core site. According to the results, compared to VB1, the VB4 strain tolerated better BAs stress and was more active in deconjugating BAs. However, BAs stress increased the bsh gene transcription in the VB1 strain but not in the VB4 strain, suggesting a partially nonlinear relationship between BSH activity and gene expression. In conclusion, despite the complexity of the BSH transcriptional system, the results support the VB4 strain as a promising BAs-deconjugating probiotic candidate.

8 October 2025 in Nutrients
Verified
Journal Article
Open access
PDF file
Amanda VaccalluzzoAmanda Vaccalluzzo
Amanda Vaccalluzzo
Gianluigi AgolinoGianluigi Agolino
Gianluigi Agolino
ALESSANDRA PINOALESSANDRA PINO
ALESSANDRA PINO
Marianna CristofoliniMarianna Cristofolini
Marianna Cristofolini
Davide TagliazucchiDavide Tagliazucchi
Davide Tagliazucchi
Cinzia Lucia  RandazzoCinzia Lucia Randazzo
Cinzia Lucia Randazzo
Background: Bile salt hydrolase (BSH) is a key probiotic trait, as it facilitates both host metabolism and bacterial survival into the gastrointestinal tract (GIT), through bile acid (BA) deconjugation, keeping intestinal homeostasis. Objectives: The present study aims to investigate the viability of the Lacticaseibacillus rhamnosus VB4 strain and its effects on bile acid deconjugation during the gastrointestinal tract (GIT) passage, under a fed condition, using the in vitro SHIME® (Simulator of the Human Intestinal Microbial Ecosystem) model. Methods: Gastric, small intestinal and colonic fractions were monitored and a fecal slurry from a healthy donor was inoculated into the colonic compartment to establish the intestinal microbiota. Samples were collected at the end of stomach, duodenum, jejunum, ileum phases, and colon after 0, 16 and 24 h. Strain survival was assessed by culturing method, and bsh gene expression was revealed by quantitative PCR (qPCR). In addition, UHPLC/HR-MS was performed to reveal the hypothetical changes in BAs profile after strain administration. Results: Good survivability of the VB4 strain in the upper GIT was revealed. Furthermore, VB4-inculated sample showed sustained expression of bsh in both the stomach/small intestine and colon fractions at all sampling times. Analysis of the BAs profile shown that the VB4 strain reduced the levels of the main conjugated BAs in the small intestine under fed condition and improved the deconjugation efficiency during colonic transit compared with the control. Conclusions: These findings highlight the survivability of L. rhamnosus VB4 strain inside the gut and its potential as biotherapeutic BAs-mediator candidate, demonstrating that transcriptomic and metabolomic approaches coupled to a dynamic in vitro gut model represent a robust tool for selection of a BSH-positive probiotic candidate.

16 September 2025 in Preprints.org
Verified
Preprint
Open access
PDF file
Amanda VaccalluzzoAmanda Vaccalluzzo
Amanda Vaccalluzzo
Gianluigi AgolinoGianluigi Agolino
Gianluigi Agolino
ALESSANDRA PINOALESSANDRA PINO
ALESSANDRA PINO
Marianna CristofoliniMarianna Cristofolini
Marianna Cristofolini
Davide TagliazucchiDavide Tagliazucchi
Davide Tagliazucchi
Cinzia Lucia  RandazzoCinzia Lucia Randazzo
Cinzia Lucia Randazzo
Bile salt hydrolase (BSH) is a key probiotic trait, as it facilitates both host metabolism and bacterial survival into the gastrointestinal tract (GIT), through bile acid (BA) deconjugation, keeping intestinal homeostasis. The present study aims to investigate the viability of the Lacticaseibacillus rhamnosus VB4 strain and its effects on bile acid deconjugation during the gastrointestinal tract (GIT) passage, under a FED condition, using the in vitro SHIME® (Simulator of the Human Intestinal Microbial Ecosystem) model. For this purpose, gastric, small intestinal and colonic fractions were monitored and a fecal slurry from a healthy donor was inoculated into the colonic compartment to establish the intestinal microbiota. Samples were collected at the end of stomach, duodenum, jejunum, ileum phases, and colon after 0, 16 and 24 hours. Strain survival was assessed by culturing method, and bsh gene expression was revealed by quantitative PCR. In addition, UHPLC/HR-MS was performed to reveal the hypothetical changes in BAs profile after strain administration. The results showed good survivability of the VB4 strain in the upper GIT. Additionally, VB4-inoculated samples displayed sustained bsh expression over time until the colon reactors. Analysis of the BAs profile shown that the VB4 strain reduced the levels of the main conjugated BAs in the small intestine under FED condition and improved the deconjugation efficiency during colonic transit compared with the control. Overall, these findings highlight the functional resilience of L. rhamnosus VB4 inside the gut and its potential as biotherapeutic BAs-mediator candidate, demonstrating that transcriptomic and metabolomic approaches coupled to a dynamic in vitro gut model represent a robust tool for selection of a BSH-positive probiotic candidate.

22 August 2025 in Research Square
Verified
Preprint
Open access
PDF file
Gianluigi AgolinoGianluigi Agolino
Gianluigi Agolino
Marianna CristofoliniMarianna Cristofolini
Marianna Cristofolini
MRMaria Anna Ronsivalle
Maria Anna Ronsivalle
Alice CattivelliAlice Cattivelli
Alice Cattivelli
Davide TagliazucchiDavide Tagliazucchi
Davide Tagliazucchi
Cinzia Lucia  RandazzoCinzia Lucia Randazzo
Cinzia Lucia Randazzo
In the present study, Levilactobacillus brevis M3R3, isolated from traditional Sicilian sourdough, was evaluated for BSH functionality through kinetic growth and bile salts (BSs) deconjugation using UHPLC/HR-MS. Genome sequencing and in silico analysis were performed to assess its safety and probiotic potential. Results showed that the M3R3 strain tolerated different concentrations of conjugated BSs, with dose-dependent growth inhibition. In particular, exposure to 1.0% taurocholic and taurodeoxycholic acids reduced M3R3 growth, indicating an adaptive stress response. When a mixed BSs solution was used to mimic intestinal conditions, M3R3 maintained its growth, despite an extended lag phase and a reduced final biomass, likely due to toxic BSs accumulation. UHPLC/HR-MS confirmed a complete deconjugation of glyco-conjugated BSs and a partial deconjugation of the tauro-conjugated BSs. Whole-genome sequencing (2.30 Mbp, 2375 CDSs) revealed no antimicrobial resistance or virulence genes and identified two bsh genes (bsh_2A and bsh_3A), both expressed under control and BS-exposed conditions. Phylogenetic analysis of L. brevis BSH proteins identified three BSH clusters (I, II, and III), and bsh2 and bsh3 genes present in M3R3 strains were grouped in clusters II and III, respectively. Overall, genomic and functional characterizations support that L. brevis M3R3 is a safe and BSH-active strain, highlighting its potential as a functional ingredient in health promoting applications.